Key Highlights
- Sigma Healthcare (ASX:SIG) rose 0.35% over five days to 20 November, compared with a 5.18% decline in the S&P/ASX 200.
- Australian Chemist Warehouse branded-store sales increased 12.1%, with like-for-like sales up 9.8%, from 1 July to 16 October.
- International branded-store sales rose 30.2% at constant currency in the three months to September, including 15.8% growth on a like-for-like basis.
- Sigma expected double-digit growth for Chemist Warehouse branded stores over the balance of the first half of FY27.
Sigma Healthcare (ASX:SIG) rose 0.35% to AUD 2.89 over the five days ending on 20 November 2026, with the S&P/ASX 200 down 5.18% for the same period. The pharmacy group’s October trading update reported double-digit Chemist Warehouse sales growth in Australia and overseas, using different reporting cut-off dates.
Sigma was among three stocks that rose
The S&P/ASX 200 dropped 469.70 points to 8,592.60 over the five days, a decline of 5.18%. That put Sigma 5.53 percentage points ahead of the benchmark over the five days. The AUD 0.01 move in Sigma took the price from an implied starting level of AUD 2.88 to AUD 2.89.
In the same five-day window, Woolworths rose 0.26%, Telstra rose 0.98% and CSL fell 1.75%. Sigma recorded the second-largest percentage gain of the three stocks that advanced.
Two store networks and two reporting cut-offs
Sigma’s 21 October update covered trading at Chemist Warehouse branded stores ahead of the pharmacy network’s Christmas period. In Australia, total sales were up 12.1% between 1 July and 16 October compared with the equivalent period, and like-for-like sales grew 9.8%. The two measures cover the same dates, with the like-for-like figure giving sales growth on a comparable basis.
The international trading figures used a cut-off of 30 September. International network sales rose 30.2% and like-for-like sales increased 15.8%, with both figures presented in constant currency. The overseas disclosure covered the first three months of the financial year, while the Australian figures included the first 16 days of October. Across both networks, total sales growth exceeded like-for-like growth on Sigma’s measures. The update gave network sales growth figures for branded stores in each market. The Australian like-for-like figure was 2.3 percentage points below the total growth rate. For the international network, which reports at constant currency and uses the earlier cut-off, the corresponding gap was 14.4 percentage points.
Store openings and differences across product categories
Sigma reported softness in discretionary categories including women’s fragrances, vitamins and supplements. The company identified better trading in beauty, healthcare and products supporting people using GLP-1 medicines. It said the sales comparison had passed the initial uplift when GLP-1 products were introduced. Sigma expected oral GLP-1 formulations to enter the market in the second half of FY27.
The company said its global pharmacy network was nearing 1,000 stores. Its Australian Chemist Warehouse network accounted for less than 10% of more than 5,900 domestic community pharmacy licences. Sigma expected to onboard 14 Chemist Warehouse stores and 42 Amcal and Discount Drug Stores in Australia in the first half, along with 19 additional stores internationally. The group also identified work on its Amcal and Discount Drug Stores networks as part of its domestic plans. The company issued the trading update on the day of its annual general meeting. Its forecast for the remainder of the half applied to Chemist Warehouse branded-store sales across its retail network.
Trading into the holidays
Sigma gained one Australian cent over the five-day period while the index fell. The company’s October update recorded sales growth in both branded networks and said it expected double-digit growth in branded-store sales over the rest of the first half.



_11_20_2026_20_27_34_097200.jpg)


Please wait processing your request...